An avirulent G1 glycoprotein variant of La Crosse Bunyavirus with defective fusion function

F. Gonzalez-Scarano, R. S. Janssen, J. A. Najjar, N. Pobjecky, N. Nathanson

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

La Crosse virus, a member of the California serogroup of the family Bunyaviridae, causes encephalitis in humans and laboratory rodents. A variant virus (V22) selected with a monoclonal antibody against the large (G1) glycoprotein showed diminished neuroinvasiveness after peripheral inoculation. This variant has an alteration in its fusion function, requiring a lower pH for the activation of fusion and demonstrating reduced efficiency of cell-to-cell fusion of BHK-21 cultures. V22 was studied in detail following the infection by intraperitoneal or intracerebral routes in suckling, weanling, or adult CD-1 mice. It exhibited a marked reduction in its ability to replicate in striated muscle and to produce viremia; however, after intracerebral injection V22 virus replicated almost as rapidly in brain as its parent, La Crosse virus. V22 virus thus represents an example of reduced neuroinvasiveness associated with an alteration at a specific epitope of the G1 glycoprotein. The same epitope also influences the fusion activity of the glycoprotein.

Original languageEnglish (US)
Pages (from-to)757-763
Number of pages7
JournalJournal of Virology
Volume54
Issue number3
StatePublished - 1985
Externally publishedYes

Fingerprint

Orthobunyavirus
La Crosse virus
California encephalitis virus
glycoproteins
Glycoproteins
Viruses
viruses
epitopes
Epitopes
Bunyaviridae
cell fusion
striated muscle
Striated Muscle
Cell Fusion
Viremia
viremia
Encephalitis
encephalitis
weanlings
suckling

ASJC Scopus subject areas

  • Immunology

Cite this

Gonzalez-Scarano, F., Janssen, R. S., Najjar, J. A., Pobjecky, N., & Nathanson, N. (1985). An avirulent G1 glycoprotein variant of La Crosse Bunyavirus with defective fusion function. Journal of Virology, 54(3), 757-763.

An avirulent G1 glycoprotein variant of La Crosse Bunyavirus with defective fusion function. / Gonzalez-Scarano, F.; Janssen, R. S.; Najjar, J. A.; Pobjecky, N.; Nathanson, N.

In: Journal of Virology, Vol. 54, No. 3, 1985, p. 757-763.

Research output: Contribution to journalArticle

Gonzalez-Scarano, F, Janssen, RS, Najjar, JA, Pobjecky, N & Nathanson, N 1985, 'An avirulent G1 glycoprotein variant of La Crosse Bunyavirus with defective fusion function', Journal of Virology, vol. 54, no. 3, pp. 757-763.
Gonzalez-Scarano F, Janssen RS, Najjar JA, Pobjecky N, Nathanson N. An avirulent G1 glycoprotein variant of La Crosse Bunyavirus with defective fusion function. Journal of Virology. 1985;54(3):757-763.
Gonzalez-Scarano, F. ; Janssen, R. S. ; Najjar, J. A. ; Pobjecky, N. ; Nathanson, N. / An avirulent G1 glycoprotein variant of La Crosse Bunyavirus with defective fusion function. In: Journal of Virology. 1985 ; Vol. 54, No. 3. pp. 757-763.
@article{fedfb0cd6593413ca7a23f16883f2617,
title = "An avirulent G1 glycoprotein variant of La Crosse Bunyavirus with defective fusion function",
abstract = "La Crosse virus, a member of the California serogroup of the family Bunyaviridae, causes encephalitis in humans and laboratory rodents. A variant virus (V22) selected with a monoclonal antibody against the large (G1) glycoprotein showed diminished neuroinvasiveness after peripheral inoculation. This variant has an alteration in its fusion function, requiring a lower pH for the activation of fusion and demonstrating reduced efficiency of cell-to-cell fusion of BHK-21 cultures. V22 was studied in detail following the infection by intraperitoneal or intracerebral routes in suckling, weanling, or adult CD-1 mice. It exhibited a marked reduction in its ability to replicate in striated muscle and to produce viremia; however, after intracerebral injection V22 virus replicated almost as rapidly in brain as its parent, La Crosse virus. V22 virus thus represents an example of reduced neuroinvasiveness associated with an alteration at a specific epitope of the G1 glycoprotein. The same epitope also influences the fusion activity of the glycoprotein.",
author = "F. Gonzalez-Scarano and Janssen, {R. S.} and Najjar, {J. A.} and N. Pobjecky and N. Nathanson",
year = "1985",
language = "English (US)",
volume = "54",
pages = "757--763",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "3",

}

TY - JOUR

T1 - An avirulent G1 glycoprotein variant of La Crosse Bunyavirus with defective fusion function

AU - Gonzalez-Scarano, F.

AU - Janssen, R. S.

AU - Najjar, J. A.

AU - Pobjecky, N.

AU - Nathanson, N.

PY - 1985

Y1 - 1985

N2 - La Crosse virus, a member of the California serogroup of the family Bunyaviridae, causes encephalitis in humans and laboratory rodents. A variant virus (V22) selected with a monoclonal antibody against the large (G1) glycoprotein showed diminished neuroinvasiveness after peripheral inoculation. This variant has an alteration in its fusion function, requiring a lower pH for the activation of fusion and demonstrating reduced efficiency of cell-to-cell fusion of BHK-21 cultures. V22 was studied in detail following the infection by intraperitoneal or intracerebral routes in suckling, weanling, or adult CD-1 mice. It exhibited a marked reduction in its ability to replicate in striated muscle and to produce viremia; however, after intracerebral injection V22 virus replicated almost as rapidly in brain as its parent, La Crosse virus. V22 virus thus represents an example of reduced neuroinvasiveness associated with an alteration at a specific epitope of the G1 glycoprotein. The same epitope also influences the fusion activity of the glycoprotein.

AB - La Crosse virus, a member of the California serogroup of the family Bunyaviridae, causes encephalitis in humans and laboratory rodents. A variant virus (V22) selected with a monoclonal antibody against the large (G1) glycoprotein showed diminished neuroinvasiveness after peripheral inoculation. This variant has an alteration in its fusion function, requiring a lower pH for the activation of fusion and demonstrating reduced efficiency of cell-to-cell fusion of BHK-21 cultures. V22 was studied in detail following the infection by intraperitoneal or intracerebral routes in suckling, weanling, or adult CD-1 mice. It exhibited a marked reduction in its ability to replicate in striated muscle and to produce viremia; however, after intracerebral injection V22 virus replicated almost as rapidly in brain as its parent, La Crosse virus. V22 virus thus represents an example of reduced neuroinvasiveness associated with an alteration at a specific epitope of the G1 glycoprotein. The same epitope also influences the fusion activity of the glycoprotein.

UR - http://www.scopus.com/inward/record.url?scp=0021848162&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021848162&partnerID=8YFLogxK

M3 - Article

C2 - 3889368

AN - SCOPUS:0021848162

VL - 54

SP - 757

EP - 763

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 3

ER -